Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2021 vs. Q2 2021
How the institutions holding Terns Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 36 | 34 | −2 |
| Shares | 16.6M | 16.7M | +103.8K (+0.6%) |
| Value | $203.8M | $174.3M | −$29.5M (−14.5%) |
New holders (3)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| S&T Bank | 10,000 | $104.0K | 0.02% |
| Public Employees Retirement System of Ohio | 400 | $4.00K | 0.00% |
| Wells Fargo & Company | 15 | $0 | 0.00% |
Sold out (5)
Institutions that held Terns Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Citadel Advisors LLC | 18,200 | $223.0K |
| Millennium Management LLC | 14,769 | $181.0K |
| Jane Street Group, LLC | 11,973 | $147.0K |
| Balyasny Asset Management LLC | 10,308 | $126.0K |
| Signaturefd, LLC | 60 | $1.00K |